Alzheimer amyloid-β peptides block the activation of C/EBPβ and C/EBPδ in glial cells

Biochemical and Biophysical Research Communications

Volumn 370, Issue 4, 2008, Pages 619-622

  Samuelsson, Malin ^a   Ramberg, Veronica ^a   Iverfeldt, Kerstin ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Amyloid ; C EBP; Glia; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GLIA CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELLS, CULTURED; DNA; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; NEUROGLIA; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 43049126143     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.150     Document Type: Article

References (20)

1. Alam T., An M.R., and Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J. Biol. Chem. 267 (1992) 5021-5024
2. Lekstrom-Himes J., and Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273 (1998) 28545-28548
3. Li R., Strohmeyer R., Liang Z., Lue L.F., and Rogers J. CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease. Neurobiol. Aging 25 (2004) 991-999
4. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 101 (2004) 2173-2178
5. Cardinaux J.R., Allaman I., and Magistretti P.J. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29 (2000) 91-97
6. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., and Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70 (2002) 462-473
7. Ejarque-Ortiz A., Medina M.G., Tusell J.M., Perez-Gonzalez A.P., Serratosa J., and Saura J. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 55 (2007) 178-188
8. Kelicen P., and Tindberg N. Lipopolysaccharide induces CYP2E1 in astrocytes through MAP kinase kinase-3 and C/EBPbeta and -delta. J. Biol. Chem. 279 (2004) 15734-15742
9. Perez-Capote K., Saura J., Serratosa J., and Sola C. Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli. Neurosci. Lett. 410 (2006) 25-30
10. Dudal S., Krzywkowski P., Paquette J., Morissette C., Lacombe D., Tremblay P., and Gervais F. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol. Aging 25 (2004) 861-871
11. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White III C.L., and Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86 (1989) 7611-7615
12. in t' Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M., and Stricker B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345 (2001) 1515-1521
13. Sciacca F.L., Ferri C., Licastro F., Veglia F., Biunno I., Gavazzi A., Calabrese E., Martinelli Boneschi F., Sorbi S., Mariani C., Franceschi M., and Grimaldi L.M. Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol. Aging 24 (2003) 927-931
14. Lukiw W.J. Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29 (2004) 1287-1297
15. Samuelsson M., Fisher L., and Iverfeldt K. beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells. Int. J. Mol. Med. 16 (2005) 449-453
16. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
17. Stine Jr. W.B., Dahlgren K.N., Krafft G.A., and LaDu M.J. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278 (2003) 11612-11622
18. Garzon D.J., and Fahnestock M. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J. Neurosci. 27 (2007) 2628-26235
19. Adlerz L., Beckman M., Holback S., Tehranian R., Cortes Toro V., and Iverfeldt K. Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction. Brain Res. Mol. Brain Res. 119 (2003) 62-72
20. Xiong W., Hsieh C.C., Kurtz A.J., Rabek J.P., and Papaconstantinou J. Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Res. 29 (2001) 3087-3098